<table align="center">
  <td>
    <a href="https://colab.research.google.com/github/nghiencuuthuoc/PharmApp/PharmApp.ipynb" target="_parent"><img src="https://colab.research.google.com/assets/colab-badge.svg" alt="Open In Colab"/></a>
  </td>
  <td>
    <a target="_blank" href="https://kaggle.com/kernels/welcome?src=https://github.com/nghiencuuthuoc/PharmApp/blob/master/PharmApp.ipynb"><img src="https://kaggle.com/static/images/open-in-kaggle.svg" /></a>
  </td>
</table>


![](./images/PharmApp-logo.png)
# PharmApp - Drug Discovery and Development
Copyright 2024 | Nghiên Cứu Thuốc | RD_Pharma_Plus

Email: nghiencuuthuoc@gmail.com | Web: nghiencuuthuoc.com | FB: facebook.com/nghiencuuthuoc 

LinkedIn: linkedin.com/in/nghiencuuthuoc | Zalo: +84888999311 | WhatsAapp: +84888999311

Twitter: x.com/nghiencuuthuoc | YT: youtube.com/@nghiencuuthuoc 

## antibody-drug

### What are antibody-drug conjugates (ADCs)?
Antibody-drug-conjugates (ADCs) combine chemotherapy and targeted therapy to treat certain blood cancers and cancerous tumors. Oncologists (cancer specialists) may use an ADC when cancers come back (recur), other treatments aren’t effective (refractory cancer) or cancers spread (metastasize).

This treatment works by targeting specific cancerous cells and delivering small doses of very powerful chemotherapy into the cells. The chemotherapy drugs damage or destroy cancerous cells but don’t harm nearby healthy cells. Antibody-drug conjugates can’t cure cancer. But studies show the treatments help people live longer.
